Skip to content

Utah Medical Products UTMD Income taxes at U.S. statutory rate of 21%

Income taxes at U.S. statutory rate of 21% at other companies

TFX
TeleflexTFX
21%0.0pp
Baxter International logo
Baxter InternationalBAX
21%0.0pp
Avanos Medical logo
Avanos MedicalAVNS
21%0.0pp
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity
Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.

The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's income taxes at u.s. statutory rate of 21%.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's income taxes at U.S. statutory rate of 21%?
Utah Medical Products (UTMD) reported income taxes at U.S. statutory rate of 21% of 21% in Q4 2025.
What does income taxes at U.S. statutory rate of 21% mean?
This metric quantifies the impact of the federal statutory tax rate on the company's effective tax rate reconciliation. It provides a standardized starting point for analyzing why the company's actual tax rate differs from the statutory rate. By isolating the federal component, it helps investors assess the influence of federal tax policy on the firm's bottom line.